REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CWM, LLC | 45 | $1 | 0.00% |
| Walleye Capital LLC | 5,100 | $58,497 | 0.00% |
| CITIGROUP INC | 28,000 | $321,160 | 0.00% |
| CITIGROUP INC | 49,225 | $564,610 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 139 | $1,594 | 0.00% |
| Walleye Capital LLC | 3,400 | $38,998 | 0.00% |
| UBS Group AG | 118,045 | $1,353,976 | 0.00% |
| Point72 Asset Management, L.P. | 3,100 | $35,557 | 0.00% |
| ASSETMARK, INC | 3,257 | $37,358 | 0.00% |
| COMERICA BANK | 3,454 | $39,617 | 0.00% |
| SJS Investment Consulting Inc. | 4 | $46 | 0.00% |
| VOYA INVESTMENT MANAGEMENT LLC | 33,518 | $384,451 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 1,040 | $11,648 | 0.00% |
| WOLVERINE TRADING, LLC | 17,100 | $196,137 | 0.00% |
| WOLVERINE TRADING, LLC | 25,400 | $291,338 | 0.00% |
External links
This page lists REVANCE THERAPEUTICS INC's shareholders in Q3 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.